CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice

Tailored Fill Release Performance

Gelatine offers manufacturers of drugs as well as dietary
supplements a versatile excipient that has been used in
the pharmaceutical industry for decades. Among its key
applications is capsule production: Approximately 90 per
cent of all pharmaceutical-grade gelatine is processed into
this sleek and widely-used drug dosage form. However, the
type of active ingredient, climate conditions and storage
times make different demands on a capsule’s properties. By
adjusting the production process for soft capsule gelatin, Dr
Becker of Gelita explains how we can modify the specific
effect, timing and duration of the fill release to tie in with
consumer needs.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026